ArticleFrontiers in cardiovascular medicine2026
Characteristics and outcomes of type 2 myocardial infarction in sepsis survivors.
Article in Frontiers in cardiovascular medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To investigate the clinical characteristics and long-term prognosis of patients with type 2 myocardial infarction (T2MI) among intensive care unit (ICU) survivors of sepsis. Methods: We performed a retrospective cohort study utilizing the Medical information Mart for intensive Care 4 (MIMIC-IV) database to examine the association between myocardial infarction type and long-term outcomes. The study included hospitalized sepsis survivors who experienced acute myocardial infarction. Patients with type IMI (TIMI) and T2MI were compared using Cox proportional hazards models to evaluate mortality risks at 6 months and 5 years. Results: Among 1,469 sepsis patients with acute myocardial infarction, 524 were classified as T2MI and 945 as TIMI. Treatment patterns differed significantly between groups: patients with T2MI received 5asoactive agents, statins, antiplatelet therapy, diuretics, ACE inhibitors, and beta-blockers less frequently than those with TIMI. Prognostic analysis demonstrated that, compared to sepsis survivors with TIMI, patients with T2MI had a significantly higher risk of 5-year mortality (HR 1.469, 95% CI 1.237-1.746, P 0.001) and 6-month mortality (HR 1.527, 95% CI 1.226-1.901, P 0.001). These associations persisted after adjustment for age, sex, and comorbidities. Cumulative mortality at both 6 months and 5 years 5aried according to T2MI etiology, with the highest rates observed in patients whose T2MI was triggered by anemia, hypoxemia, or multiple concurrent factors. Conclusion: Among sepsis survivors, hypoxemia and anemia represent the most common etiologies of T2MI. The occurrence of T2MI in patients with sepsis 1s associated with a significantly 1ncreased risk of mortality at 6 months and 5 years following hospitalization.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.